Pneumonia

  1. This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various vaccine approaches being worked on worldwide.
    Published: December 2018
    Type: Resource Page
  2. Oxygen therapy paired with pulse oximetry is being used to treat hypoxemia and save lives in Uganda. This brief outlines political recommendations for scaling up its use.
    Published: December 2018
    Type: Resource Page
  3. Strong national programs and civil society partnerships at all levels contribute to Kenya's progress against pneumonia and diarrhea.
    Published: November 2018
    Type: Article
  4. New vaccines on the horizon, if successful, could help resource-strapped countries make valuable headway against the world’s #1 child killer—pneumonia.
    Published: November 2018
    Type: Article
  5. This report, developed by the Advancing Maternal Immunization (AMI) collaboration, describes the activities required in the near- and mid-to long-term to generate key evidence and achieve the necessary conditions for advancing respiratory syncytial virus (RSV) maternal immunization in low- and middle-income countries. It is a companion to AMI's Advancing RSV Maternal Immunization: A Gap Analysis Report, which describes the evidence, information, and policy needs of global and country decision-makers, public health program planners, and implementers who might be involved in decision-making and introducing maternal RSV vaccines.AMI is a collaboration of cross-sectoral experts convened by PATH and WHO with the purpose of advancing RSV maternal immunization.
    Published: October 2018
    Type: Resource Page
  6. This brief summarizes the findings from a gap analysis conducted by the Advancing Maternal Immunization (AMI) collaboration of experts, which describes the evidence and policy needs of global and country decision-makers, public health program planners, and implementers that may be involved in maternal respiratory syncytial virus (RSV) vaccine decisions or delivery. This brief focuses specifically on the context of potential introduction in low- and middle-income countries and summarizes relevant evidence across the following broad topic areas: 1) disease, 2) product, 3) health economics and financing, and 4) vaccine service delivery.AMI is a collaboration of cross-sectoral experts convened by PATH and the World Health Organization with the purpose of advancing RSV maternal immunization.Related: Advancing Maternal Immunization: A Gap Analysis Report
    Published: August 2018
    Type: Resource Page
  7. A new resource sheds light on what’s needed to get ready for a new vaccine that, if approved, could help pregnant mothers protect their babies from a common cause of serious respiratory infections—respiratory syncytial virus.
    Published: August 2018
    Type: Article
  8. Access to oxygen should not be a matter of location or luck. The HO2PE campaign aims to bring the issue of oxygen access to the forefront of discussions on newborn, child and maternal health. Help PATH increase awareness about the importance of oxygen treatment and its impact on saving precious breath and life around the world by utilizing the campaign resources below.
    Published: July 2018
    Type: Article
  9. This report describes the evidence and policy needs of global and country decision-makers, public health program planners, and implementers that may be involved in maternal respiratory syncytial virus (RSV) vaccine decisions or delivery. The report focuses specifically on the context of potential introduction in low- and middle-income countries (LMICs) and summarizes relevant evidence across the following broad topic areas: 1) disease, 2) product, 3) health economics and financing, and 4) vaccine service delivery. Critical gaps in evidence are highlighted that, if left unfilled, could delay or preclude vaccine introduction in LMICs.Advancing Maternal Immunization (AMI) is a collaboration of cross-sectoral experts convened by PATH and WHO with the purpose of advancing RSV MI.
    Published: July 2018
    Type: Resource Page
  10. Ce guide aide les personnes commises au plaidoyer (les influenceurs) et les DÉCIDEURS à comprendre la nécessité d'accroître l'accès à l'oxygène et la façon de le faire, même dans des contextes où les ressources sont limitées. Il fournit des données, des messages et des ressources pouvant aider à comprendre la planification, les politiques et les technologies impliquées dans la mise à l'échelle de la distribution d'oxygène. Cet outil est utile à quiconque souhaite en savoir plus sur l'augmentation de l'accès à l'oxygène et l'intégration de la distribution d'oxygène dans les politiques, les programmes et les budgets de santé nationaux et infranationaux. L’abécédaire n’est pas marqué et reste personnalisable, ce qui permet aux défenseurs et aux décideurs d'utiliser ces ressources de la façon qui convient le mieux à leurs besoins.Version anglaise disponible ici: https://www.path.org/resources/oxygen-is-essential-a-policy-and-advocacy-primer/
    Published: July 2018
    Type: Resource Page
Load more